Reviewed by:
Prescription required
Atomoxetine is a prescription medication used to treat attention-deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. Unlike stimulant medications commonly used for ADHD, atomoxetineis a selective norepinephrine reuptake inhibitor (NRI) that helps improve focus, attention, and impulse control by boosting norepinephrine levels. It is not considered habit-forming and has a lower risk of misuse or dependence. Atomoxetine is available by prescription only and should be taken exactly as directed by your healthcare provider.
Ready to Fill
Atomoxetine
Strattera
Selective norepinephrine reuptake inhibitor (NRI)
Not a controlled medication
Capsules, oral solution (generic only)
In children and adolescents weighing ≤70 kg, treatment typically starts at 0.5 mg/kg once daily, with an increase after 3 days to a target dose of approximately 1.2 mg/kg/day, up to a maximum of 1.4 mg/kg/day or 100 mg, whichever is lower. For adults and adolescents weighing >70 kg, the usual starting dose is 40 mg once daily, which may be increased after 3 days to 80 mg once daily, with a maximum dose of 100 mg once daily, using capsules or oral solution as prescribed.
Basics
Atomoxetine is a prescription medication classified as a selective norepinephrine reuptake inhibitor (NRI). It is approved for the treatment of attention-deficit hyperactivity disorder (ADHD) and works by increasing norepinephrine levels in the brain. This neurotransmitter plays a key role in attention regulation, impulse control, and executive functioning.
Unlike stimulants, atomoxetine does not directly stimulate dopamine release in the brain’s reward pathways. Because of this, it carries a lower risk of abuse, misuse, or dependence and is not classified as a controlled substance. This makes it suitable for long-term ADHD management for those who can’t tolerate stimulants or have a history of substance sensitivity.
Note: This medication’s generic and brand-name formulations are used interchangeably throughout this article.
Strattera is the brand-name version of atomoxetine and is prescribed to treat ADHD in children, adolescents, and adults. It is typically taken once or twice daily and provides continuous symptom control throughout the day rather than the short, peak-based effects seen with stimulant medications.
Because Strattera is a non-stimulant, it may be preferred for patients who experience stimulant-related side effects such as insomnia, appetite suppression, increased anxiety, or mood swings.
While symptom improvement with Strattera may take several weeks to become noticeable, its steady mechanism of action allows for consistent therapeutic benefits without the highs and lows commonly associated with stimulant therapy.
Indications
Strattera is primarily indicated for the treatment of ADHD in both pediatric and adult populations. ADHD is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity. It helps patients improve attention spans, reduce impulsive behaviors, and control hyperactive tendencies.
Its use extends across a variety of age groups, including children 6 years and older and adults. For pediatric patients, Strattera provides an alternative when stimulant medications are not suitable due to contraindications or adverse reactions.
In adults, ADHD often presents with different challenges compared to children, and Strattera’s efficacy across life stages is valuable in comprehensive ADHD treatment plans.
Strattera’s distinct therapeutic pathway makes it a preferred option for patients who experience adverse effects from stimulant medications or for those with coexisting conditions where stimulants are not recommended.
Its long-term use requires consistent monitoring by healthcare professionals to ensure optimal therapeutic outcomes and manage any side effects that may arise.
Mechanism
Strattera works by increasing norepinephrine levels, a neurotransmitter associated with attention and impulse control. Its mechanism provides therapeutic effects that improve focus, control hyperactive behavior, and enhance the ability to organize activities.
Given its pharmacological profile, Strattera can be particularly useful in patients contraindicated for stimulant therapy or those who have not responded adequately to these interventions.
The mechanism of action of Strattera centers on its selective inhibition of norepinephrine reuptake, a key neurotransmitter involved in the regulation of attention, impulse control, and hyperactivity. Unlike stimulant medications, which primarily affect the dopamine pathways, Strattera offers a unique treatment paradigm by focusing on norepinephrine modulation.
Atomoxetine’s action is most prominent in the prefrontal cortex, a brain region heavily involved in executive function and attention regulation. By increasing norepinephrine levels in this region, Strattera enhances signal transmission, thereby improving cognitive control over attention and behavior.
This targeted action allows for symptom reduction in both the inattention and hyperactivity/impulsivity domains of ADHD.
Following administration, atomoxetine is well absorbed, with peak plasma concentrations typically achieved within 1-2 hours. The medication is metabolized in the liver, primarily via the cytochrome P450 2D6 pathway, leading to interindividual variation in metabolic rates.
Note that, due to this variability, Strattera requires individualized dosing adjustments to achieve optimal therapeutic efficacy while minimizing adverse effects.
Critical Dosing Note: Approximately 7% of Caucasians and a smaller percentage of other populations are CYP2D6 poor metabolizers, which can cause Strattera blood levels to rise up to 10× higher than normal, increasing the risk of severe side effects even at standard doses; warning signs include extreme insomnia, resting heart rate over 100 bpm, or severe nausea at low doses, and affected individuals may require significant dose reduction or genetic testing for confirmation.
Dosage
Strattera is supplied as capsules for oral administration. The dosing regimen is largely contingent upon the patient’s weight and therapeutic needs, necessitating careful consideration by healthcare professionals.
Strattera can be administered with or without food, providing flexibility to accommodate patient preferences and minimize gastrointestinal side effects.
Many healthcare providers recommend administering Strattera in the morning or early afternoon to align with the natural circadian rhythm, enhancing daytime symptom control while minimizing the risk of sleep disturbances.
Patients must follow their healthcare provider’s dosing instructions to ensure optimal benefit and manage any potential side effects.
While the onset of therapeutic effects might not be immediate, many individuals begin to observe symptom improvement within a few weeks of consistent use, with maximum benefits sometimes taking up to 8 weeks. The medication’s half-life permits once-daily or twice-daily dosing, thereby maintaining consistent symptom control throughout the day.
The distinct non-stimulant property of Strattera also means it does not exacerbate anxiety or lead to the rebound effects commonly associated with stimulant medications.
Why pay retail prices for the same medication?
At Invictus, we source directly from trusted, FDA-approved manufacturers to keep your costs low without sacrificing quality. Whether you need a one-time fill or regular refills, our transparent pricing makes it easy to save every day.
Side Effects
While Strattera is generally well-tolerated, like all medications, it can cause a range of side effects—from mild discomfort to more serious health concerns.
The most frequently reported side effects of Strattera are mild to moderate and often improve as the body adjusts to the medication over time.
Although serious side effects are rare, they can occur and require immediate medical evaluation.
Regular check-ins with a healthcare provider, particularly during the early stages of therapy, can help ensure that the treatment remains safe, effective, and well-suited to the individual’s needs.
Interactions
Strattera can interact with a range of medications and substances, potentially increasing side effect risks or altering therapeutic effectiveness. Understanding how Strattera interacts with other medications is vital to optimizing its efficacy and minimizing hazardous side effects.
Patients should always inform their healthcare provider about all prescription and over-the-counter medications, vitamins, and herbal supplements they are taking. This enables careful monitoring, dose adjustment, or substitution with safer alternatives where necessary.
Contraindications
Strattera (atomoxetine) can interact with several medications and substances, which may alter its effectiveness or increase the risk of side effects. Because Strattera works by increasing norepinephrine levels in the brain—a neurotransmitter that also affects heart rate and blood pressure—certain combinations of drugs can amplify its stimulant-like cardiovascular effects.
Understanding these interactions is essential to using Strattera safely and getting the most out of treatment for ADHD or related conditions.
In all cases, open communication with a healthcare provider is the best safeguard against harmful drug interactions. Never start, stop, or adjust the dose of any medication without medical advice. Regular monitoring of blood pressure, heart rate, and mood during Strattera therapy helps ensure safe and effective treatment.
The information provided on this page is for general informational purposes only and is not intended as medical advice. Always consult with a licensed healthcare provider before starting, stopping, or changing any medication regimen. While Invictus strives to provide accurate and up-to-date information, individual health conditions and circumstances vary. The prices, availability, and descriptions of all medications on this page are subject to change.
Your Prescription
Ready to Fill
Need Help?